Part of the reason COA recommended a 'ramp up' period is we need time for the vendors to understand what they need to be incorporating in their software, said Michael Diaz, MD, president of Community Oncology Alliance.
Part of the reason COA recommended a 'ramp up' period is we need time for the vendors to understand what they need to be incorporating in their software, said Michael Diaz, MD, president of Community Oncology Alliance.
Transcipt:
When the Oncology Care First Model (OCF) was first released, there was discussion about practices capturing electronic patient reported outcomes. Can you discuss how this would work?
Well, that's another reason why it might be a good idea to not have such an aggressive timeline and why we're asking for a little bit of a delay. First of all, those components are not fundamentally existing in the electronical medical records that we have. So part of the reason why we need a "ramp up" period is because we need to allow time for the vendors to understand what they need to be incorporating in their software. Because right now, I'm sure they'd love to make the changes, but they don't know what needs to be changed in the electronical health record. Those changes need to be instituted from the vendor. Then the practices have to learn and understand how and what's expected to go into those data fields. It's not like flipping a switch, it would be ideal if we could make changes that quickly. But unfortunately, the delivery of cancer care and all the processes involved just to make that happen, are pretty complex. In order to make sure that it's done right and it's done properly, we want to make sure that we know what we're dealing with, that we have the technology, that we know that it works, that we know that our practices know and understand how to use it and what's expected out of them. It would be great if it were as simple as flipping a switch, but unfortunately, that's not the reality.
An Elevated Member Experience, More Education, and Martha Stewart at the AAD 2025 Annual Meeting
March 4th 2025Seemal R Desai, MD, FAAD, president of the American Academy of Dermatology (AAD), emphasized his commitment to enhancing the upcoming 2025 annual meeting by introducing new events and expanding educational offerings to better serve and engage members.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
NSCLC Advancements Offer Hope, but Disparities Persist
February 20th 2025Ioana Bonta, MD, Georgia Cancer Specialists, discusses the evolving state of non-small cell lung cancer (NSCLC) treatments, their impact on patient outcomes, and the need to address ongoing disparities in these populations.
Read More
Understanding TB Symptoms, Spread, Treatment Amid Kansas City Outbreak
February 13th 2025In part 2 of this interview, Michael A. Bernstein, MD, highlights the need for prolonged antibiotics and strong public health measures to combat tuberculosis (TB) at both the individual and population levels.
Read More